BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 24495594)

  • 21. Clinical outcomes of biological effective dose-based fractionated stereotactic radiation therapy for metastatic brain tumors from non-small cell lung cancer.
    Matsuyama T; Kogo K; Oya N
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):984-90. PubMed ID: 23092725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukoencephalopathy after whole-brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancer.
    Monaco EA; Faraji AH; Berkowitz O; Parry PV; Hadelsberg U; Kano H; Niranjan A; Kondziolka D; Lunsford LD
    Cancer; 2013 Jan; 119(1):226-32. PubMed ID: 22707281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
    Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
    Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases.
    Atalar B; Modlin LA; Choi CY; Adler JR; Gibbs IC; Chang SD; Harsh GR; Li G; Nagpal S; Hanlon A; Soltys SG
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):713-8. PubMed ID: 24054875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open-label phase II study.
    Chua D; Krzakowski M; Chouaid C; Pallotta MG; Martinez JI; Gottfried M; Curran W; Throuvalas N
    Clin Lung Cancer; 2010 May; 11(3):176-81. PubMed ID: 20439193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
    Singh C; Qian JM; Yu JB; Chiang VL
    J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival.
    Gielda BT; Mehta P; Khan A; Marsh JC; Zusag TW; Warren WH; Fidler MJ; Abrams RA; Bonomi P; Liptay M; Faber LP
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):985-91. PubMed ID: 20932684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relevance of gamma knife radiosurgery alone for the treatment of non-small cell lung cancer brain metastases.
    Zairi F; Ouammou Y; Le Rhun E; Aboukais R; Blond S; Vermandel M; Deken V; Devos P; Reyns N
    Clin Neurol Neurosurg; 2014 Oct; 125():87-93. PubMed ID: 25108698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation Study.
    Hepel JT; Leonard KL; Safran H; Ng T; Taber A; Khurshid H; Birnbaum A; ; Wazer DE; DiPetrillo T
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1021-1027. PubMed ID: 27745983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upfront radiosurgery plus targeted agents followed by active brain control using radiosurgery delays neurological death in non-small cell lung cancer with brain metastasis.
    Lee SW; Kim YS; Sung SY; Kwak YK; Kang YN; Jang JS; Kang JH; Hong SH; Kim SJ; Jung SL
    Clin Exp Metastasis; 2020 Apr; 37(2):353-363. PubMed ID: 32008137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotactic radiotherapy for patients who initially presented with brain metastases from non-small cell carcinoma.
    Nakayama H; Tokuuye K; Komatsu Y; Ishikawa H; Shiotani S; Nakada Y; Akine Y
    Acta Oncol; 2004; 43(8):736-9. PubMed ID: 15764218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases].
    Yue X; Zang QC
    Ai Zheng; 2004 Dec; 23(12):1671-6. PubMed ID: 15601558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for brain metastases in locally advanced non-small cell lung cancer with definitive chest radiation.
    Ji Z; Bi N; Wang J; Hui Z; Xiao Z; Feng Q; Zhou Z; Chen D; Lv J; Liang J; Fan C; Liu L; Wang L
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):330-7. PubMed ID: 24725335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis.
    Rodrigues G; Oberije C; Senan S; Tsujino K; Wiersma T; Moreno-Jimenez M; Kim TH; Marks LB; Rengan R; De Petris L; Ramella S; DeRuyck K; De Dios NR; Warner A; Bradley JD; Palma DA
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):133-9. PubMed ID: 25835622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
    Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.